Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients

Chiara Fabbri, Daniel Souery, Raffaella Calati, Concetta Crisafulli, Armando Chierchia, Diego Albani, Gianluigi Forloni, Alberto Chiesa, Rosalba Martines, Othman Sentissi, Julien Mendlewicz, Giovanni De Girolamo, Alessandro Serretti

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The treatment of bipolar disorder (BD) usually requires combination therapies, with the critical issue of the emergence of adverse drug reactions (ADRs) and the possibility of low treatment adherence. Genetic polymorphisms are hypothesized to modulate the pharmacodynamics of psychotropic drugs, representing potential biological markers of ADRs. This study investigated genes involved in the regulation of neuroplasticity (BDNF, ST8SIA2), second messenger cascades (GSK3B, MAPK1, and CREB1), circadian rhythms (RORA), transcription (SP4, ZNF804A), and monoaminergic system (HTR2A and COMT) in the risk of neurological, psychic, autonomic, and other ADRs. Two independent samples of BD patients naturalistically treated were included (COPE-BD n = 147; STEP-BD n = 659). In the COPE-BD 34 SNPs were genotyped, while in the STEP-BD polymorphisms in the selected genes were extracted from the genome-wide dataset. Each ADRs group was categorized as absent-mild or moderate-severe and logistic regression with appropriate covariates was applied to identify possible risk genotypes/alleles. 58.5 and 93.5 % of patients were treated with mood stabilizers, 44.2 and 50.7 % were treated with antipsychotics, and 69.4 and 46.1 % were treated with antidepressants in the COPE-BD and STEP-BD, respectively. Our findings suggested that ST8SIA2 may be associated with psychic ADRs, as shown in the COPE-BD (rs4777989 p = 0.0017) and STEP-BD (rs56027313, rs13379489 and rs10852173). A cluster of RORA SNPs around rs2083074 showed an effect on psychic ADRs in the STEP-BD. Trends supporting the association between HTR2A and autonomic ADRs were found in both samples. Confirmations are needed particularly for ST8SIA2 and RORA since the few available data regarding their role in relation to psychotropic ADRs.

Original languageEnglish
Pages (from-to)43-58
Number of pages16
JournalJournal of Neural Transmission
Volume122
Issue number1
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Bipolar Disorder
Drug-Related Side Effects and Adverse Reactions
Psychotropic Drugs
Single Nucleotide Polymorphism
Autonomic Agents
Neuronal Plasticity
Brain-Derived Neurotrophic Factor
Second Messenger Systems
Genetic Polymorphisms
Circadian Rhythm
Antidepressive Agents
Antipsychotic Agents
Genes
Therapeutics
Biomarkers
Logistic Models
Alleles
Genotype
Genome
N-succinyl-1,2-dioleoylphosphatidylethanolamine

Keywords

  • Antidepressant
  • Antipsychotic
  • Gene
  • Mood stabilizer
  • Pharmacogenetics
  • Side effect

ASJC Scopus subject areas

  • Biological Psychiatry
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Medicine(all)

Cite this

Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients. / Fabbri, Chiara; Souery, Daniel; Calati, Raffaella; Crisafulli, Concetta; Chierchia, Armando; Albani, Diego; Forloni, Gianluigi; Chiesa, Alberto; Martines, Rosalba; Sentissi, Othman; Mendlewicz, Julien; De Girolamo, Giovanni; Serretti, Alessandro.

In: Journal of Neural Transmission, Vol. 122, No. 1, 01.01.2015, p. 43-58.

Research output: Contribution to journalArticle

Fabbri, C, Souery, D, Calati, R, Crisafulli, C, Chierchia, A, Albani, D, Forloni, G, Chiesa, A, Martines, R, Sentissi, O, Mendlewicz, J, De Girolamo, G & Serretti, A 2015, 'Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients', Journal of Neural Transmission, vol. 122, no. 1, pp. 43-58. https://doi.org/10.1007/s00702-014-1290-3
Fabbri, Chiara ; Souery, Daniel ; Calati, Raffaella ; Crisafulli, Concetta ; Chierchia, Armando ; Albani, Diego ; Forloni, Gianluigi ; Chiesa, Alberto ; Martines, Rosalba ; Sentissi, Othman ; Mendlewicz, Julien ; De Girolamo, Giovanni ; Serretti, Alessandro. / Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients. In: Journal of Neural Transmission. 2015 ; Vol. 122, No. 1. pp. 43-58.
@article{724f96a15c8f4daaae2f1314216401b9,
title = "Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients",
abstract = "The treatment of bipolar disorder (BD) usually requires combination therapies, with the critical issue of the emergence of adverse drug reactions (ADRs) and the possibility of low treatment adherence. Genetic polymorphisms are hypothesized to modulate the pharmacodynamics of psychotropic drugs, representing potential biological markers of ADRs. This study investigated genes involved in the regulation of neuroplasticity (BDNF, ST8SIA2), second messenger cascades (GSK3B, MAPK1, and CREB1), circadian rhythms (RORA), transcription (SP4, ZNF804A), and monoaminergic system (HTR2A and COMT) in the risk of neurological, psychic, autonomic, and other ADRs. Two independent samples of BD patients naturalistically treated were included (COPE-BD n = 147; STEP-BD n = 659). In the COPE-BD 34 SNPs were genotyped, while in the STEP-BD polymorphisms in the selected genes were extracted from the genome-wide dataset. Each ADRs group was categorized as absent-mild or moderate-severe and logistic regression with appropriate covariates was applied to identify possible risk genotypes/alleles. 58.5 and 93.5 {\%} of patients were treated with mood stabilizers, 44.2 and 50.7 {\%} were treated with antipsychotics, and 69.4 and 46.1 {\%} were treated with antidepressants in the COPE-BD and STEP-BD, respectively. Our findings suggested that ST8SIA2 may be associated with psychic ADRs, as shown in the COPE-BD (rs4777989 p = 0.0017) and STEP-BD (rs56027313, rs13379489 and rs10852173). A cluster of RORA SNPs around rs2083074 showed an effect on psychic ADRs in the STEP-BD. Trends supporting the association between HTR2A and autonomic ADRs were found in both samples. Confirmations are needed particularly for ST8SIA2 and RORA since the few available data regarding their role in relation to psychotropic ADRs.",
keywords = "Antidepressant, Antipsychotic, Gene, Mood stabilizer, Pharmacogenetics, Side effect",
author = "Chiara Fabbri and Daniel Souery and Raffaella Calati and Concetta Crisafulli and Armando Chierchia and Diego Albani and Gianluigi Forloni and Alberto Chiesa and Rosalba Martines and Othman Sentissi and Julien Mendlewicz and {De Girolamo}, Giovanni and Alessandro Serretti",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/s00702-014-1290-3",
language = "English",
volume = "122",
pages = "43--58",
journal = "Journal of Neural Transmission",
issn = "0300-9564",
publisher = "Springer-Verlag Wien",
number = "1",

}

TY - JOUR

T1 - Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients

AU - Fabbri, Chiara

AU - Souery, Daniel

AU - Calati, Raffaella

AU - Crisafulli, Concetta

AU - Chierchia, Armando

AU - Albani, Diego

AU - Forloni, Gianluigi

AU - Chiesa, Alberto

AU - Martines, Rosalba

AU - Sentissi, Othman

AU - Mendlewicz, Julien

AU - De Girolamo, Giovanni

AU - Serretti, Alessandro

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The treatment of bipolar disorder (BD) usually requires combination therapies, with the critical issue of the emergence of adverse drug reactions (ADRs) and the possibility of low treatment adherence. Genetic polymorphisms are hypothesized to modulate the pharmacodynamics of psychotropic drugs, representing potential biological markers of ADRs. This study investigated genes involved in the regulation of neuroplasticity (BDNF, ST8SIA2), second messenger cascades (GSK3B, MAPK1, and CREB1), circadian rhythms (RORA), transcription (SP4, ZNF804A), and monoaminergic system (HTR2A and COMT) in the risk of neurological, psychic, autonomic, and other ADRs. Two independent samples of BD patients naturalistically treated were included (COPE-BD n = 147; STEP-BD n = 659). In the COPE-BD 34 SNPs were genotyped, while in the STEP-BD polymorphisms in the selected genes were extracted from the genome-wide dataset. Each ADRs group was categorized as absent-mild or moderate-severe and logistic regression with appropriate covariates was applied to identify possible risk genotypes/alleles. 58.5 and 93.5 % of patients were treated with mood stabilizers, 44.2 and 50.7 % were treated with antipsychotics, and 69.4 and 46.1 % were treated with antidepressants in the COPE-BD and STEP-BD, respectively. Our findings suggested that ST8SIA2 may be associated with psychic ADRs, as shown in the COPE-BD (rs4777989 p = 0.0017) and STEP-BD (rs56027313, rs13379489 and rs10852173). A cluster of RORA SNPs around rs2083074 showed an effect on psychic ADRs in the STEP-BD. Trends supporting the association between HTR2A and autonomic ADRs were found in both samples. Confirmations are needed particularly for ST8SIA2 and RORA since the few available data regarding their role in relation to psychotropic ADRs.

AB - The treatment of bipolar disorder (BD) usually requires combination therapies, with the critical issue of the emergence of adverse drug reactions (ADRs) and the possibility of low treatment adherence. Genetic polymorphisms are hypothesized to modulate the pharmacodynamics of psychotropic drugs, representing potential biological markers of ADRs. This study investigated genes involved in the regulation of neuroplasticity (BDNF, ST8SIA2), second messenger cascades (GSK3B, MAPK1, and CREB1), circadian rhythms (RORA), transcription (SP4, ZNF804A), and monoaminergic system (HTR2A and COMT) in the risk of neurological, psychic, autonomic, and other ADRs. Two independent samples of BD patients naturalistically treated were included (COPE-BD n = 147; STEP-BD n = 659). In the COPE-BD 34 SNPs were genotyped, while in the STEP-BD polymorphisms in the selected genes were extracted from the genome-wide dataset. Each ADRs group was categorized as absent-mild or moderate-severe and logistic regression with appropriate covariates was applied to identify possible risk genotypes/alleles. 58.5 and 93.5 % of patients were treated with mood stabilizers, 44.2 and 50.7 % were treated with antipsychotics, and 69.4 and 46.1 % were treated with antidepressants in the COPE-BD and STEP-BD, respectively. Our findings suggested that ST8SIA2 may be associated with psychic ADRs, as shown in the COPE-BD (rs4777989 p = 0.0017) and STEP-BD (rs56027313, rs13379489 and rs10852173). A cluster of RORA SNPs around rs2083074 showed an effect on psychic ADRs in the STEP-BD. Trends supporting the association between HTR2A and autonomic ADRs were found in both samples. Confirmations are needed particularly for ST8SIA2 and RORA since the few available data regarding their role in relation to psychotropic ADRs.

KW - Antidepressant

KW - Antipsychotic

KW - Gene

KW - Mood stabilizer

KW - Pharmacogenetics

KW - Side effect

UR - http://www.scopus.com/inward/record.url?scp=84928228660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928228660&partnerID=8YFLogxK

U2 - 10.1007/s00702-014-1290-3

DO - 10.1007/s00702-014-1290-3

M3 - Article

C2 - 25129258

AN - SCOPUS:84928228660

VL - 122

SP - 43

EP - 58

JO - Journal of Neural Transmission

JF - Journal of Neural Transmission

SN - 0300-9564

IS - 1

ER -